Statin

President Bush's cut to AIDS prevention in Africa would be devastating

Twenty-eight years after intense selective logging stopped in the region now known as Uganda's Kibale National Park, the red-tailed guenon (Cercophithecus ascanius) is a primate still in decline. The logging practice, scientists report in a new study, changed the ecological balance for these monkeys, leading to behavioral changes and opening the door for multiple parasitic infections. The...

Novel targets found for the development of drugs to complement, or replace, statins

Leading marine scientists for the first time have assessed dolphin and porpoise populations around the world which are severely threatened by entanglement in fishing gear and recommended nine urgent priorities for action in a report commissioned by the World Wildlife Fund. These nine projects highlight species threatened by bycatch that will most likely benefit from immediate action and will cont...

Quick identification needed to save Florida's citrus industry from devastating disease

The recent discovery of citrus greening (huanglongbing) in samples collected from trees in South Florida poses a definite threat to Florida's $9 billion commercial citrus industry. Proper identification and eradication methods are needed to reduce the amount of crop loss caused by this disease, say plant pathologists with The American Phytopathological Society (APS). Citrus greening is a bacteria...

Intensive statin therapy may partially reverse plaque build-up in arteries

A study presented today at the American College of Cardiology's 55th Annual Scientific Session demonstrates, for the first time, that very intensive cholesterol lowering with a statin drug can regress (partially reverse) the buildup of plaque in the coronary arteries. This finding has never before been observed in a study using statin drugs, the most commonly used cholesterol lowering tr...

Statins have neutral effect on risk of cancer

The cholesterol-lowering medications called statins do not appear to reduce the incidence of cancer or cancer deaths, according to a meta-analysis of previous studies in the January 4 issue of JAMA. Other studies have suggested that statins reduce the risk of developing cancer, the authors provide as background information in the review article. "Statins have been studied in numerous larg...

More>>

Statin at Biology Products

Canine Endostatin EIA Kit from Neogen Corporation

Description:Detection of Total Canine Endostatin. Canine Cytokine EIA Kits(Competitive Format) Neogens Life Science products include a line of enzyme-linked immunosorbent assay (ELISA) test kits and reagents used for multiple research applications. The line of ELISA test kits are ultra-sensitive, quick and dependable assays. The quantitative test kits detect hormones, steroids, prostaglandins, le...
Company:Neogen Corporation

Mouse Oncostatin M from StemCell Technologies, Inc.

Description:Oncostatin M (OSM) is a pleiotropic cytokine produced by activated T cells, monocytes, and Kaposis sarcoma cells. OSM inhibits the growth of some tumour and normal cell lines, simulates fibroblast, smooth muscle and Kaposis sarcoma cell proliferation, cytokine release from endothelial cells and low density lipoprotein receptor expression on hepatoma cells. Mouse OSM was recently cloned and identi...
Company:StemCell Technologies, Inc.

Rabbit Anti-Somatostatin 28 Polyclonal Antibody, Unconjugated from Abcam

Description:Rabbit polyclonal to Somatostatin 28 ( SwissProtID: P61278...
Company:Abcam

Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems

Description:Human Cystatin A MAb (Clone 224705)...
Company:R&D Systems

Goat Anti-cystatin A (N-18) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Description:cystatin A (N-18)...
Company:Santa Cruz Biotechnology, Inc.

More>>

Statin at Biology Technology

The development of a somatostatin sst4 receptor-binding assay using the LEADseeker Multimodality Imaging System

Somatostatin (SS) is a neurotransmitter/hormone with a wide range of biological actions (1–3) and a reduction in cortical SS levels has been reported in Alzheimer’s and Parkinson’s diseases. The SS analog...

Statin at Medicine News

Statins reduce heart attacks

New guidelines issued recently could mean that as many as one in six American adults could be advised to take one of a class of prescription drugs called statins. The recommendations of the National Cholesterol Education Program (NCEP) could triple the number of Americans taking statins. The panel hopes that expanded use of the drugs -- with improved diets and more exercise -- will help reduce th...

Simvastatin Plus Niacin May Lower Heart Risks

Treatment combining the cholesterol drug simvastatin with the B vitamin niacin lowers the risk of heart attack and other artery-disease complications by up to 90% in some patients. The study of 160 adults with clogged heart arteries and low HDL (good) cholesterol showed that 3 years of the combo treatment improved HDL levels, caused artery blockages to recede and significantly lowered heart compl...

Statins reduce risks for angioplasty patients

Cholesterol-lowering drugs that help prevent heart disease also appear to cut the risk of a heart attack and other complications after angioplasty.// Angioplasty, an alternative to bypass surgery, allows doctors to open clogged coronary arteries without major surgery by inserting a tiny balloon to the narrowest point and inflating the balloon. But 3 of every 5 patients who go through the procedur...

Further support for use of statins in Alzheimer’s disease

People who take the cholesterol-lowering drugs called statins may reduce their risk of developing Alzheimer's disease by nearly 80%. Statins have been proved to offer// powerful protection against heart disease for people with high blood cholesterol. The findings provide the strongest evidence to date that statin drugs may also help protect people from Alzheimer's disease. An earlier,...

Myostatin gene could hold the key to treatment for DMD

Recent studies to establish an effective treatment for Duchenne Muscular Dystrophy (DMD) have discovered that drugs or molecules used to inhibit myostatin - a protein that inhibits muscle growth - might prove to be the anticipated// answer. MDA grantee Kathryn Wagner of John Hopkins University showed in a new study, published online, that muscle mass and strength in mice with DMD is in...

More>>

Statin at Medicine Products

Cystatin C, Serum

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Mammastatin Serum Assay

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Somatostatin

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Statin at Medicine Technology

Study Presented at ACC Shows Treatment With ISIS 301012 Added to Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C Levels of Less Than 70 mg/dL

* ISIS 301012 coadministered with statins for only five weeks at400 mg/week lowered LDL-C 47% beyond the levels achieved withstatins alone, with similarly favorable effects on otheratherogenic lipids NEW ORLEANS and CARLSBAD, Calif., March 26, 2007/PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. announced newresults from its Phase 2 clinical trial of ISIS 301012coadministered with st...